Is it true that pre-conization high-risk HPV DNA load is a significant factor of persistence of HPV infection after conization?

Journal of Clinical Virology

Volumn 55, Issue 4, 2012, Pages 377-378

  Broccolo, Francesco ^a   Fusetti, Lisa ^b   Ceccherini Nelli, Luca ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

GENOTYPE; HUMAN; LETTER; MEDICAL DEVICE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION; WART VIRUS;

CERVIX UTERI; CONIZATION; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; VIRAL LOAD;

EID: 84867842965     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.08.003     Document Type: Letter

References (10)

1. Dalstein V., Riethmuller D., Pretet J.L., Le Bail C., Sautiere J.L., Carbillet J.P., et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003, 106:396-403.
2. Schlecht N.F., Trevisan A., Duarte-Franco E., Rohan T., Ferenczy A., Villa L.L., et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003, 103:519-524.
3. Kanamori Y., Kigawa J., Minagawa Y., Irie T., Oishi, Itamochi H., et al. Residual disease and presence of human papillomavirus after conization. Oncology 1998, 55:517-520.
4. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y., et al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 2004, 190:1046-1051.
5. Song S.H., Lee J.K., Oh M.J., Hur J.Y., Na J.Y., Park Y.K., et al. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 2006, 101:418-422.
6. Alonso I., Torne A., Puig-Tintore L.M., Esteve R., Quinto L., Campo E., et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006, 103:631-636.
7. Park J.Y., Lee K.H., Dong S.M., Kang S., Park S.Y., Seo S.S. The association of pre-conization high-risk HPV load and the persistent of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol 2008, 108:549-554.
8. Nam K., Chung S., Kim J., Jeon S., Bae D. Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 2009, 20(2):91-95.
9. Bae J.H., Kim C.J., Park T.C., Namkoong S.E., Park J.S. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer 2007, 17:1271-1277.
10. Broccolo F., Chiari S., Piana A., Castiglia P., Dell'Anna T., Garcia-Parra R., et al. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of north Italy. J Med Virol 2009, 81:278-287.